pHR-Traditional CAR (anti-CD19) Citations (1)
Originally described in: High-performance multiplex drug-gated CAR circuits.Li HS, Wong NM, Tague E, Ngo JT, Khalil AS, Wong WW Cancer Cell. 2022 Aug 26. pii: S1535-6108(22)00372-5. doi: 10.1016/j.ccell.2022.08.008. PubMed Journal
Articles Citing pHR-Traditional CAR (anti-CD19)
| Articles |
|---|
| Directly reprogrammed NK cells driven by BCL11B depletion enhance targeted immunotherapy against pancreatic ductal adenocarcinoma. Kim HS, Kim JY, Lee JY, Seol B, Choi JE, Cho YS. J Hematol Oncol. 2025 Nov 13;18(1):100. doi: 10.1186/s13045-025-01730-1. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.